Login Register Cart 0
Generic placeholder image

Current Drug Research Reviews

Editor-in-Chief

ISSN (Print): 2589-9775
ISSN (Online): 2589-9783

Back
Journal Home About Journal Editorial Board Current Issue Volumes/Issues
Subscribe
Review Article

Skin Cancer: An Insight on its Association with Aging, Pathogenesis and Treatment Strategies

Author(s): Divya Sharma, Nikhil Singh and Shikha Srivastava*

Volume 16, Issue 2, 2024

Published on: 20 July, 2023

Page: [134 - 144] Pages: 11

DOI: 10.2174/2589977515666230627154048

Price: $65

Abstract

Skin cancer is one of the deadly diseases of the skin characterized by pain and uncontrolled growth of cells. The pathogenesis of skin cancer involves the uncontrolled division of abnormal cells in the part of the body affected by an accumulation of genome variation over the course of a lifetime. The incidence of skin cancer has been increasing all over the world and has been reported more in old-aged persons. Furthermore, aging plays a vital role in promoting malignancy. Cancer necessitates lifelong administration of drugs to maintain the quality of life. The major challenge of treatment is the side effects associated with these drugs. Novel and targeted approaches are now formulated to explore as an alternative measure to treat cancer. The current review summarizes the pathogenesis of cancer and its treatment strategies. These approaches are discussed with regard to the drugs, mechanism of action, causative factors, distribution of cancer, mortality rate, and treatment strategies.

« Previous Next »
Graphical Abstract

[1]
Li H, Wang Z, Ma T, Wei G, Ni T. Alternative splicing in aging and age-related diseases. Transl Med Aging 2017; 1: 32-40.
[http://dx.doi.org/10.1016/j.tma.2017.09.005]
[2]
Guo J, Huang X, Dou L, et al. Aging and aging-related diseases: From molecular mechanisms to interventions and treatments. Signal Transduct Target Ther 2022; 7(1): 391.
[http://dx.doi.org/10.1038/s41392-022-01251-0] [PMID: 36522308]
[3]
Cho JH, Lee JG, Yang YI, et al. Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells. Food Chem Toxicol 2011; 49(8): 1737-44.
[http://dx.doi.org/10.1016/j.fct.2011.04.019] [PMID: 21554918]
[4]
Hu W, Fang L, Ni R, Zhang H, Pan G. Changing trends in the disease burden of non-melanoma skin cancer globally from 1990 to 2019 and its predicted level in 25 years. BMC Cancer 2022; 22(1): 836.
[http://dx.doi.org/10.1186/s12885-022-09940-3] [PMID: 35907848]
[5]
Winsey SL, Haldar NA, Marsh HP, et al. A variant within the DNA repair gene XRCC3 is associated with the development of melanoma skin cancer. Cancer Res 2000; 60(20): 5612-6.
[PMID: 11059748]
[6]
Yélamos O, Geller S, Tokez S. Skin cancer special issue in Skin Health and Disease. Skin Health Dis 2023; 3(2)e224
[http://dx.doi.org/10.1002/ski2.224] [PMID: 37013119]
[7]
Armstrong BK, Kricker A. The epidemiology of UV induced skin cancer. J Photochem Photobiol B 2001; 63(1-3): 8-18.
[http://dx.doi.org/10.1016/S1011-1344(01)00198-1] [PMID: 11684447]
[8]
Sone S, Takashima S, Li F, et al. Mass screening for lung cancer with mobile spiral computed tomography scanner. Lancet 1998; 351(9111): 1242-5.
[http://dx.doi.org/10.1016/S0140-6736(97)08229-9] [PMID: 9643744]
[9]
Ho MM, Ng AV, Lam S, Hung JY. Side population in human lung cancer cell lines and tumors is enriched with stem-like cancer cells. Cancer Res 2007; 67(10): 4827-33.
[http://dx.doi.org/10.1158/0008-5472.CAN-06-3557] [PMID: 17510412]
[10]
Tabar L, Yen MF, Vitak B, Chen HHT, Smith RA, Duffy SW. Mammography service screening and mortality in breast cancer patients: 20-year follow-up before and after introduction of screening. Lancet 2003; 361(9367): 1405-10.
[http://dx.doi.org/10.1016/S0140-6736(03)13143-1] [PMID: 12727392]
[11]
Hariharan D, Saied A, Kocher HM. Analysis of mortality rates for pancreatic cancer across the world. HPB 2008; 10(1): 58-62.
[http://dx.doi.org/10.1080/13651820701883148] [PMID: 18695761]
[12]
Moore MJ, Goldstein D, Hamm J, et al. Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 2007; 25(15): 1960-6.
[http://dx.doi.org/10.1200/JCO.2006.07.9525] [PMID: 17452677]
[13]
Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136(5): E359-86.
[http://dx.doi.org/10.1002/ijc.29210] [PMID: 25220842]
[14]
Bruce AF, Theeke L, Mallow J. A state of the science on influential factors related to sun protective behaviors to prevent skin cancer in adults. Int J Nurs Sci 2017; 4(3): 225-35.
[http://dx.doi.org/10.1016/j.ijnss.2017.05.005] [PMID: 31406745]
[15]
Lai YCC, Chang SJ, Kostoro J, Kwan AL, Chai CY. Vascular adhesion protein-1 as indicator of breast cancer tumor aggressiveness and invasiveness. Acta Pathol Microbiol Scand Suppl 2018; 126(9): 755-61.
[http://dx.doi.org/10.1111/apm.12885] [PMID: 30160019]
[16]
Gao X, Zhang Y, Mons U, Brenner H. Leukocyte telomere length and epigenetic-based mortality risk score: associations with all-cause mortality among older adults. Epigenetics 2018; 13(8): 846-57.
[http://dx.doi.org/10.1080/15592294.2018.1514853] [PMID: 30152726]
[17]
Chen Y, Li J, Liu X, Geng Z, Xu K, Su J. Advances in biomarkers and diagnostic significance of organ aging. Fundamental Research. Fundamental Research. In Press 2023.
[http://dx.doi.org/10.1016/j.fmre.2023.03.009]
[18]
Schellnegger M, Lin AC, Hammer N, Kamolz LP. Physical activity on telomere length as a biomarker for aging: A systematic review. Sports Med Open 2022; 8(1): 111.
[http://dx.doi.org/10.1186/s40798-022-00503-1] [PMID: 36057868]
[19]
Kenneaster DG. Introduction to skin cancer. Oral Maxillofac Surg Clin North Am 2005; 17(2): 133-42.
[http://dx.doi.org/10.1016/j.coms.2005.02.001] [PMID: 18088772]
[20]
Hodi FS, O’Day SJ, McDermott DF, et al. Improved survival with ipilimumab in patients with metastatic melanoma. N Engl J Med 2010; 363(8): 711-23.
[http://dx.doi.org/10.1056/NEJMoa1003466] [PMID: 20525992]
[21]
Worrede A, Douglass SM, Weeraratna AT. The dark side of daylight: Photoaging and the tumor microenvironment in melanoma progression. J Clin Invest 2021; 131(6)e143763
[http://dx.doi.org/10.1172/JCI143763] [PMID: 33720046]
[22]
Jain N, Valli KS, Devi VK. Importance of novel drug delivery systems in herbal medicines. Pharmacogn Rev 2010; 4(7): 27-31.
[http://dx.doi.org/10.4103/0973-7847.65322] [PMID: 22228938]
[23]
Ling B, Michel D, Sakharkar M, Yang J. Evaluating the cytotoxic effects of the water extracts of four anticancer herbs against human malignant melanoma cells. Drug Des Devel Ther 2016; 10: 3563-72.
[http://dx.doi.org/10.2147/DDDT.S119214] [PMID: 27843296]
[24]
Kirkwood TBL. Understanding the odd science of aging. Cell 2005; 120(4): 437-47.
[http://dx.doi.org/10.1016/j.cell.2005.01.027] [PMID: 15734677]
[25]
Al-Dujaili Z, Henry M, Dorizas AS, Sadick NS. Skin cancer concerns particular to women. Int J Womens Dermatol 2017; 3(S1): S49-51.
[http://dx.doi.org/10.1016/j.ijwd.2017.02.009] [PMID: 28492039]
[26]
Harborne JB, Williams CA. Advances in flavonoid research since 1992. Phytochemistry 2000; 55(6): 481-504.
[http://dx.doi.org/10.1016/S0031-9422(00)00235-1] [PMID: 11130659]
[27]
Krutmann J, Bouloc A, Sore G, Bernard BA, Passeron T. The skin aging exposome. J Dermatol Sci 2017; 85(3): 152-61.
[http://dx.doi.org/10.1016/j.jdermsci.2016.09.015] [PMID: 27720464]
[28]
Srivastava S, Kapoor S, Saraf S. Novel preparation and evaluation of lotion containing aloe gel beads. Indian J Pharm Educ Res 2008; 42(2): 170-3.
[29]
Kuwano T, Nakao S, Yamamoto H, et al. Cyclooxygenase 2 is a key enzyme for inflammatory cytokine-induced angiogenesis. FASEB J 2004; 18(2): 300-10.
[http://dx.doi.org/10.1096/fj.03-0473com] [PMID: 14769824]
[30]
Orthaber K, Pristovnik M, Skok K, Perić B, Maver U. Skin cancer and its treatment: Novel treatment approaches with emphasis on nanotechnology. J Nanomater 2017; 2017: 1-20.
[http://dx.doi.org/10.1155/2017/2606271]
[31]
Paolino D, Cosco D, Cilurzo F, Fresta M. Innovative drug delivery systems for the administration of natural compounds. Curr Bioact Compd 2007; 3(4): 262-77.
[http://dx.doi.org/10.2174/157340707783220301]
[32]
Millsop JW, Sivamani RK, Fazel N. Botanical agents for the treatment of nonmelanoma skin cancer. Dermatol Res Pract 2013; 2013: 1-9.
[http://dx.doi.org/10.1155/2013/837152] [PMID: 23983679]
[33]
Sonavane K, Phillips J, Ekshyyan O, et al. Topical curcumin-based cream is equivalent to dietary curcumin in a skin cancer model. J Skin Cancer 2012; 2012147863
[http://dx.doi.org/10.1155/2012/147863]
[34]
Wei H, Bowen R, Zhang X, Lebwohl M. Isoflavone genistein inhibits the initiation and promotion of two-stage skin carcinogenesis in mice. Carcinogenesis 1998; 19(8): 1509-14.
[http://dx.doi.org/10.1093/carcin/19.8.1509] [PMID: 9744550]
[35]
Srivastava S, Singh D, Patel S, Parihar AKS, Singh MR. Novel carters and targeted approaches: Way out for rheumatoid arthritis quandrum. J Drug Deliv Sci Technol 2017; 40: 125-35.
[http://dx.doi.org/10.1016/j.jddst.2017.05.025]
[36]
Saraf S, Gupta MK. Itraconazole loaded ethosomal gel system for efficient treatment of skin cancer. Int J Drug Deliv 2018; 10(1): 12-9.
[37]
Patel S, Singh D, Srivastava S, et al. Nanoparticles as a platform for antimicrobial drug delivery. Adv Pharmacol 2017; 5(3): 31-43.
[http://dx.doi.org/10.13189/app.2017.050301]
[38]
Goette DK. Topical chemotherapy with 5-fluorouracil. J Am Acad Dermatol 1981; 4(6): 633-49.
[http://dx.doi.org/10.1016/S0190-9622(81)80196-X] [PMID: 7016939]
[39]
Nguyen TH, Ho DQD. Nonmelanoma skin cancer. Curr Treat Options Oncol 2002; 3(3): 193-203.
[http://dx.doi.org/10.1007/s11864-002-0009-0] [PMID: 12057065]
[40]
Wölfle U, Seelinger G, Schempp CM. Topical application of St. Johnʼs wort (Hypericum perforatum). Planta medica 2014; 80(02/03): 109-20.
[41]
Abdelbary A, Salem HF, AbdelSalam Khallaf R. Niosomal 5-Flourouracil gel for effective treatment of skin cancer; In-vitro and In-vivo evaluation. Int J Drug Deliv 2016; 7(4): 223-32.
[42]
Eaglstein WH, Weinstein GD, Frost P. Fluorouracil: Mechanism of action in human skin and actinic keratoses. I. Effect on DNA synthesis in vivo. Arch Dermatol 1970; 101(2): 132-9.
[http://dx.doi.org/10.1001/archderm.1970.04000020002002] [PMID: 5413250]
[43]
Wilkes GM. Vismodegib, a hedgehog pathway inhibitor for adults with locally advanced or metastatic basal cell carcinoma. Oncol Nurs 2012; 26(8)
[44]
Jain S, Song R, Xie J. Sonidegib: Mechanism of action, pharmacology, and clinical utility for advanced basal cell carcinomas. OncoTargets Ther 2017; 10: 1645-53.
[http://dx.doi.org/10.2147/OTT.S130910] [PMID: 28352196]
[45]
Samatar AA, Poulikakos PI. Targeting RAS–ERK signalling in cancer: Promises and challenges. Nat Rev Drug Discov 2014; 13(12): 928-42.
[http://dx.doi.org/10.1038/nrd4281] [PMID: 25435214]
[46]
List T, Neri D. Immunocytokines: A review of molecules in clinical development for cancer therapy. Clin Pharmacol 2013; 5(5 S1): 29-45.
[http://dx.doi.org/10.2147/CPAA.S49231]
[47]
Ibrahim RA, Berman DM, DePril V, et al. Ipilimumab safety profile: Summary of findings from completed trials in advanced melanoma. J Clin Oncol 2011; 29(S15): 8583.
[http://dx.doi.org/10.1200/jco.2011.29.15_suppl.8583]
[48]
Motzer RJ, Rini BI, McDermott DF, et al. Nivolumab for metastatic renal cell carcinoma: Results of a randomized phase II trial. J Clin Oncol 2015; 33(13): 1430-7.
[http://dx.doi.org/10.1200/JCO.2014.59.0703] [PMID: 25452452]
[49]
Jagadeeshan S, David D, Jisha S, Manjula S, Asha Nair S. Solanum nigrum Unripe fruit fraction attenuates Adriamycin resistance by down-regulating multi-drug resistance protein (Mdr)-1 through Jak-STAT pathway. BMC Complement Altern Med 2017; 17(1): 370.
[http://dx.doi.org/10.1186/s12906-017-1872-3] [PMID: 28720093]
[50]
Munteanu MF, Ardelean A, Borcan F, et al. Mistletoe and garlic extracts as polyurethane carriers - a possible remedy for choroidal melanoma. Curr Drug Deliv 2017; 14(8): 1178-88.
[PMID: 28128068]
[51]
Marvibaigi M, Supriyanto E, Amini N, Abdul Majid FA, Jaganathan SK. Preclinical and clinical effects of mistletoe against breast cancer. BioMed Res Int 2014; 2014: 1-15.
[http://dx.doi.org/10.1155/2014/785479] [PMID: 25136622]
[52]
Chen CC, Kao CP, Chiu MM, Wang SH. The anti-cancer effects and mechanisms of Scutellaria barbata D. Don on CL1-5 lung cancer cells. Oncotarget 2017; 8(65): 109340-57.
[http://dx.doi.org/10.18632/oncotarget.22677] [PMID: 29312612]
[53]
Zare-Zardini H, Taheri-Kafrani A, Amiri A, Bordbar AK. New generation of drug delivery systems based on ginsenoside Rh2-, Lysine- and Arginine-treated highly porous graphene for improving anticancer activity. Sci Rep 2018; 8(1): 586.
[http://dx.doi.org/10.1038/s41598-017-18938-y] [PMID: 29330486]
[54]
Bharadwaj R, Das PJ, Pal P, Mazumder B. Topical delivery of paclitaxel for treatment of skin cancer. Drug Dev Ind Pharm 2016; 42(9): 1482-94.
[http://dx.doi.org/10.3109/03639045.2016.1151028] [PMID: 26850463]
[55]
Alzohairy MA. Therapeutics role of Azadirachta indica (Neem) and their active constituents in diseases prevention and treatment. Evid Based Complement Alternat Med 2016; 2016: 1-11.
[http://dx.doi.org/10.1155/2016/7382506] [PMID: 27034694]
[56]
Jensen JD, Dunn JH, Luo Y, Liu W, Fujita M, Dellavalle RP. Ellagic acid inhibits melanoma growth in vitro. Dermatol Rep 2011; 3(3)e36
[http://dx.doi.org/10.4081/dr.2011.e36] [PMID: 25386288]
[57]
Kim ES. Avelumab: First global approval. Drugs 2017; 77(8): 929-37.
[http://dx.doi.org/10.1007/s40265-017-0749-6] [PMID: 28456944]
[58]
Ivan A, Herman H, Balta C, et al. Berberis vulgaris extract/β-cyclodextrin complex increases protection of hepatic cells via suppression of apoptosis and lipogenesis pathways. Exp Ther Med 2017; 13(5): 2143-50.
[http://dx.doi.org/10.3892/etm.2017.4240] [PMID: 28565821]
[59]
Darvin P, Joung YH, Kang DY, et al. Tannic acid inhibits EGFR/STAT1/3 and enhances p38/STAT1 signalling axis in breast cancer cells. J Cell Mol Med 2017; 21(4): 720-34.
[http://dx.doi.org/10.1111/jcmm.13015] [PMID: 27862996]
[60]
Lee CW, Na Y, Park N, et al. Amentoflavone inhibits UVB-induced matrix metalloproteinase-1 expression through the modulation of AP-1 components in normal human fibroblasts. Appl Biochem Biotechnol 2012; 166(5): 1137-47.
[http://dx.doi.org/10.1007/s12010-011-9500-z] [PMID: 22205321]
[61]
Thorat KJ, Yamgar TS, Shirote PJ, Deshmane B. A review on stability of aloe vera gel. Res J Top Cosmet Sci 2018; 9(1): 7-11.
[http://dx.doi.org/10.5958/2321-5844.2018.00003.1]
[62]
Kumar S, Hosokawa M, Miyashita K. Fucoxanthin: A marine carotenoid exerting anti-cancer effects by affecting multiple mechanisms. Mar Drugs 2013; 11(12): 5130-47.
[http://dx.doi.org/10.3390/md11125130] [PMID: 24351910]
[63]
Padmavathi B, Rath PC, Rao AR, Singh RP. Roots of Withania somnifera inhibit forestomach and skin carcinogenesis in mice. Evid Based Complement Alternat Med 2005; 2(1): 99-105.
[http://dx.doi.org/10.1093/ecam/neh064] [PMID: 15841284]
[64]
Yan X, Qi M, Li P, Zhan Y, Shao H. Apigenin in cancer therapy: anti-cancer effects and mechanisms of action. Cell Biosci 2017; 7(1): 50.
[http://dx.doi.org/10.1186/s13578-017-0179-x] [PMID: 29034071]
[65]
Cornacchia L, Roos YH. Beta-carotene delivery systems stabilised by dairy proteins. Food Process Engineering in a Changing World—Proceedings of the International Congress of Engineering and Food Athens. Cosmoswa Greece. 2011; pp. 2: 2925-6.
[66]
Lopes LB, VanDeWall H, Li HT, et al. Topical delivery of lycopene using microemulsions: Enhanced skin penetration and tissue antioxidant activity. J Pharm Sci 2010; 99(3): 1346-57.
[http://dx.doi.org/10.1002/jps.21929] [PMID: 19798758]
[67]
Davidov-Pardo G, McClements DJ. Nutraceutical delivery systems: Resveratrol encapsulation in grape seed oil nanoemulsions formed by spontaneous emulsification. Food Chem 2015; 167: 205-12.
[http://dx.doi.org/10.1016/j.foodchem.2014.06.082] [PMID: 25148980]
[68]
Sui X, Zhang C, Zhou J, et al. Resveratrol inhibits Extranodal NK/T cell lymphoma through activation of DNA damage response pathway. J Exp Clin Cancer Res 2017; 36(1): 133.
[http://dx.doi.org/10.1186/s13046-017-0601-6] [PMID: 28950914]
[69]
Jee SH, Shen SC, Kuo M-L, Tseng C-R, Chiu H-C. Curcumin induces a p53-dependent apoptosis in human basal cell carcinoma cells. J Invest Dermatol 1998; 111(4): 656-61.
[http://dx.doi.org/10.1046/j.1523-1747.1998.00352.x] [PMID: 9764849]
[70]
Zhu M, Zhang Y, Cooper S, Sikorski E, Rohwer J, Bowden GT. Phase II enzyme inducer, sulforaphane, inhibits UVB-induced AP-1 activation in human keratinocytes by a novel mechanism. Mol Carcinog 2004; 41(3): 179-86.
[71]
Davids LM, Kleemann B, Kacerovská D, Pizinger K, Kidson SH. Hypericin phototoxicity induces different modes of cell death in melanoma and human skin cells. J Photochem Photobiol B 2008; 91(2-3): 67-76.
[http://dx.doi.org/10.1016/j.jphotobiol.2008.01.011] [PMID: 18342534]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy